These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6990546)

  • 21. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
    Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
    Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
    Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation.
    Lagarde M; Drouot B; Guichardant M; Dechavanne M
    Biochim Biophys Acta; 1985 Jan; 833(1):52-8. PubMed ID: 3917687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets.
    Markwardt F; Hoffmann A; Stürzebecher J
    Haemostasis; 1983; 13(4):227-33. PubMed ID: 6618289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 28. Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187.
    Vargaftig BB; Fouque F; Chignard M
    Thromb Res; 1980 Jan 1-15; 17(1-2):91-102. PubMed ID: 6246654
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells.
    Campbell WB; Falck JR; Okita JR; Johnson AR; Callahan KS
    Biochim Biophys Acta; 1985 Oct; 837(1):67-76. PubMed ID: 3931686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.
    Polley MJ; Nachman RL
    J Exp Med; 1979 Sep; 150(3):633-45. PubMed ID: 479764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin as an antithrombotic medication.
    Marcus AJ
    N Engl J Med; 1983 Dec; 309(24):1515-7. PubMed ID: 6358887
    [No Abstract]   [Full Text] [Related]  

  • 34. Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis.
    Reeve EB
    Thromb Res; 1980 Apr 1-15; 18(1-2):19-31. PubMed ID: 6157218
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical evaluation of platelet aggregation in whole human blood.
    Riess H; Braun G; Brehm G; Hiller E
    Am J Clin Pathol; 1986 Jan; 85(1):50-6. PubMed ID: 3079628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin and dazoxiben as inhibitors of platelet behaviour: modification of their effects by agents that alter cAMP production.
    Sills T; Cowley AJ; Heptinstall S
    Thromb Res; 1986 Apr; 42(1):91-8. PubMed ID: 3010495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of phospholipase C in platelet responses.
    Lapetina EG; Siess W
    Life Sci; 1983 Sep; 33(11):1011-8. PubMed ID: 6412009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions between stimulated platelets and endothelial cells in vitro.
    Marcus AJ; Broekman MJ; Weksler BB; Jaffe EA; Safier LB; Ullman HL; Tack-Goldman K
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):343-53. PubMed ID: 6117896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: Platelet aggregation induced by a synthetase-like substance and phospholipase-A.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Thromb Diath Haemorrh; 1975 Sep; 34(1):315-6. PubMed ID: 1188718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.